Bispecific engineered antibody domains (nanoantibodies) that interact noncompetitively with an HIV-1 neutralizing epitope and FcRn. by Rui Gong, Yanping Wang, Tianlei Ying, Dimiter S Dimitrov

Get full text

Enhancing vaccine half-life as a novel strategy for improving immune response durability of subunit vaccines. by Zhaoling Shen, Cheng Li, Wenping Song, Litong Liu, Yu Kong, Ailing Huang, Qingui Bao, Tianlei Ying, Yanling Wu

Get full text

Functional mapping of B-cell linear epitopes of SARS-CoV-2 in COVID-19 convalescent population by Zhigang Yi, Yun Ling, Xiaonan Zhang, Jieliang Chen, Kongying Hu, Yuyan Wang, Wuhui Song, Tianlei Ying, Rong Zhang, HongZhou Lu, Zhenghong Yuan

Get full text

Correction: Fan et al. A Human DPP4-Knockin Mouse’s Susceptibility to Infection by Authentic and Pseudotyped MERS-CoV. <i>Viruses</i> 2018, <i>10</i>, 448 by Changfa Fan, Xi Wu, Qiang Liu, Qianqian Li, Susu Liu, Jianjun Lu, Yanwei Yang, Yuan Cao, Weijin Huang, Chunnan Liang, Tianlei Ying, Shibo Jiang, Youchun Wang

Get full text

Inhaled bispecific single-domain antibody BM219 for mild-to-moderate COVID-19: a double-blind, randomized, placebo-controlled phase 2 trial by Yanling Wu, Yuan Li, Ping Zhang, Siwei Guo, Fang Yuan, Vivian Liu, Ting Yu, Feng Lin, Nan Yang, Chao Tu, Hongzhou Lu, Tianlei Ying, Xin Li

Get full text